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Speciﬁc cell adhesionmolecules (CAMs) are dedicated to the formation of axo-glial contacts
at the nodes of Ranvier of myelinated axons. They play a central role in the organization
and maintenance of the axonal domains: the node, paranode, and juxtaparanode. In
particular, CAMs are essential for the accumulation of voltage-gated sodium channels at
the nodal gap that ensures the rapid and saltatory propagation of the action potentials
(APs). The mechanisms regulating node formation are distinct in the central and peripheral
nervous systems, and recent studies have highlighted the relative contribution of paranodal
junctions and nodal extracellular matrix. In addition, CAMs at the juxtaparanodal domains
mediate the clustering of voltage-gated potassium channels which regulate the axonal
excitability. In several human pathologies, the axo-glial contacts are altered leading to
disruption of the nodes of Ranvier or mis-localization of the ion channels along the axons.
Node alterations and the failure of APs to propagate correctly from nodes to nodes along
the axons both contribute to the disabilities in demyelinating diseases. This article reviews
themechanisms regulating the association of the axo-glial complexes and the role of CAMs
in inherited and acquired neurological diseases.
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INTRODUCTION
In vertebrate, most axons are insulated by myelin sheaths and
the action potentials (APs) are regenerated at the nodes of Ran-
vier which enable the rapid saltatory propagation of the nerve
impulses. The myelin is formed by glial cells: Schwann cells in
peripheral nervous system (PNS) and oligodendrocytes in cen-
tral nervous system (CNS). The mechanisms underlying myelin
formation are complex and involve interactions between neu-
rons and glial cells. Myelination begins with the contact and
recognition of the axon by the glial processes. The glial pro-
cesses then wrap around the axon, form multiple layers of myelin,
and elongate along the axon. Simultaneously, the myelinating
glial cells organize the axonal domains: nodes, paranodes, and
juxtaparanodes. First, the voltage-gated Na+ (Nav) channels are
aggregated at hemi-nodes which border the myelinated segments
(Vabnick et al., 1996). These hemi-nodes then fuse into a node
of Ranvier as the myelin segments grow and approach each over
(See Figure 2). At both sides of the nodes, the myelin spirals
around the axon forming paranodal loops. Electron microscopic
observations revealed that the paranodal loops form septate-like
junctions with the axon (Einheber et al., 1997). These junctions
may preclude current leakage across the paranodes and favor
rapid propagation. Recent evidences indicate that the associa-
tion of Contactin-1/Caspr-1/Neurofascin-155 (NF155) is required
for the formation of the septate-like junctions. In addition, these
junctions favor the sequestration of the voltage-gated potassium
channels (VGKCs; Kv), Kv1.1/Kv1.2/Kv1.6, in the juxtaparanodal
regions (Vabnick et al., 1999). The localization of the Nav and
Kv channels is strongly dependent on cell adhesion molecules
(CAMs) at nodes, paranodes, and juxtaparanodes. Alterations of
the axo-glial interaction contribute to the etiology of numerous
neurological diseases. This article reviews recent ﬁndings docu-
menting the implication of CAMs in axon specialization and in
neurological diseases.
MOLECULAR ORGANIZATION OF THE AXONAL DOMAINS OF
MYELINATED FIBERS
NEUROFASCIN-186, NrCAM, AND GLIOMEDIN: STRUCTURE AND
FUNCTION AT PNS NODES
During development, the clustering of Nav is strongly dependent
on the axo-glial contact at PNS nodes of Ranvier (Melendez-
Vasquez et al., 2001), but also on two scaffolding proteins, ankyrin-
G and βIV-spectrin, which links the nodal proteins to the actin
cytoskeleton (Jenkins and Bennett, 2002; Komada and Soriano,
2002; Yang et al., 2004; Devaux, 2010). In the PNS, the myelinating
Schwann cells form the nodal microvilli which face the nodes of
Ranvier. Several CAMs expressed at nodal axolemma or secreted
by Schwann cells at the nodal lumen mediate the axo-glial contact
and the clustering of Nav channels (Nav1.2 andNav1.6) at nodes of
Ranvier (Caldwell et al., 2000; Boiko et al., 2001). Neurofascin-186
(NF186) and NrCAM belong to the L1-family of CAMs and are
concentrated at the nodes of Ranvier (Davis et al., 1996). NF186 is
expressed at the nodal axolemma only. By contrast, NrCAM exists
as both an axonal form and a form secreted by the Schwann cell
microvilli (Feinberg et al., 2010).
Both NF186 and NrCAM bind Gliomedin, an extracellu-
lar matrix component secreted by the Schwann cell microvilli
(Figure 1A). Gliomedin contains a coiled-coil, two collagen-like,
and one olfactomedin domain (Eshed et al., 2005). Gliomedin
exists as both transmembrane and secreted forms (Eshed et al.,
Frontiers in Cellular Neuroscience www.frontiersin.org October 2013 | Volume 7 | Article 196 | 1
“fncel-07-00196” — 2013/10/27 — 17:54 — page 2 — #2
Faivre-Sarrailh and Devaux Neuro-glial interactions at nodes
FIGURE 1 | Organization of CNS and PNS nodes of Ranvier. (A) At PNS
nodes, NF186 binds Gliomedin (Gldn) and NrCAM which are secreted by
Schwann cells in the nodal gap lumen. The cytoplasmic region of axonal
NF186 and NrCAM bind ankyrin-G, which anchors the nodal complex to
βIV-spectrin and to the actin cytoskeleton. Ankyrin-G enables the clustering of
Nav and Kv7.2/7.3 channels at nodes. (B) In the CNS, Tenascin-R (TN-R),
Brevican (Bcan), Versican (Vcan), and Phosphacan (Phcan) are enriched in the
extracellular matrix surrounding the nodes, and stabilize the nodal complex.
These molecules bind NF186, NrCAM, and Contactin-1 which are expressed
at CNS nodes. (C)The complex Contactin-1/Caspr-1/NF155 forms the
septate-like junctions at both PNS and CNS paranodes. This complex is
stabilized by the cytosolic protein 4.1B which co-localizes with ankyrin-B, αII-
and βII-spectrin at both paranodes and juxtaparanodes. (D)The complex
Contactin-2/Caspr-2 enables the sequestration of Kv1.1/Kv1.2/Kv1.6 channels
at juxtaparanodes, but also of PSD-93 and PSD-95. ADAM22 and Connexin-29
(Cx29) are also enriched at juxtaparanodes.
2007; Maertens et al., 2007). However, solely the secreted form,
generated by proteolytic cleavage with furin and BMP-1 enzymes,
is detected at the nodes of Ranvier. The release of the C-terminal
olfactomedin domain favors its oligomerization, its incorporation
in the extracellular matrix, and its interaction with NF186. The
interactions between Gliomedin, NF186, and NrCAM are criti-
cal for the initial clustering of the Nav channels at hemi-nodes.
In the developing sciatic nerve or in myelinating co-cultures of
dorsal root ganglion (DRG) with Schwann cells, the clustering of
nodal components (Nav channels, ankyrin-G, NF186, NrCAM,
and Gliomedin) is ﬁrst detected at hemi-nodes at the edge of
each myelinated segment (See Figure 2). Deﬁciency in Gliomedin,
NF186, or NrCAM prevents the initial clustering of the Nav chan-
nels at hemi-nodes both in vivo and in vitro (Feinberg et al., 2010).
Nonetheless, Nav channel aggregation is not prevented at mature
nodes in Gliomedin- or NrCAM-deﬁcient animals. As detailed
below, mature nodes are ﬂanked by paranodal septate junctions
that likely mediate a barrier to the lateral diffusion of the nodal
components. Thus, the organization of the PNS nodes depends on
axo-glial contacts at nodes and paranodes. The role of NF186 in
the organization of mature PNS nodes is, however, controversial.
Some studies have shown that NF186 is crucial for the formation
of PNSnodes (Dzhashiashvili et al., 2007; Thaxton et al., 2011), but
others have shown that deleting NF186 does not alter nodal orga-
nization which is maintained by paranodal junctions (Sherman
et al., 2005; Zonta et al., 2008; Feinberg et al., 2010).
Recent evidences have underpinned the mechanisms regulat-
ing the targeting of nodal components at PNS nodes (Zhang
et al., 2012). It appears that nodal CAMs (NF186, NrCAM, and
Gliomedin) accumulate to nascent nodes from local sources via
diffusion trapping. Nav channels and ankyrin-G, by contrast, are
transported to the nodes, and show a slow turnover in mature
nodes. The exact mechanisms regulating the selective incorpora-
tion of the transported proteins at nodes remained, however, to be
elucidated.
The nodal CAMs present several interacting modules which
participate in the axo-glial contact. NF186 contains a mucin-
related domain, three Fibronectin type III (FnIII) and six Ig
domains (Figure 1). NrCAM is composed of four FnIII and six
Ig domains (Figure 1). The Ig domains of NrCAM and NF186
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FIGURE 2 | Soluble FnIII domains of NF186 inhibit the clustering of
Gliomedin and Nav channels at hemi-nodes. These are PNS
myelinating co-cultures of DRG neurons with Schwann cells that have
been triple-stained for MBP (blue), Caspr or Gliomedin (red), and Nav
channels (green). Myelination was induced with ascorbic acid after 7 days
in vitro. Co-cultures were treated with control Fc or with the FnIII
domains of NF186 fused with Fc (NF186Fn-Fc) from day 7 to day 24.
Gliomedin (Gldn) and Nav channels are clustered at hemi-nodes and
ﬂanked the paranodes and myelin borders in myelinating co-cultures.
Incubation with NF186Fn-Fc abrogated the clustering of Gliomedin and
Nav channels at hemi-nodes, but not at mature nodes of Ranvier. This
indicated that the interaction between NF186 and Gliomedin is crucial for
the formation of hemi-node clusters. Scale bar: 10 μm. Adapted from
Labasque et al. (2011).
are crucial for their heterophilic interaction (Volkmer et al., 1996).
Particularly, NF186 interacts with NrCAM in trans via its Ig1–4
domains (Labasque et al., 2011). Deletion of the Ig domains of
NF186 abolishes its accumulation at nodes (Dzhashiashvili et al.,
2007), indicating that the Ig domains are crucial for the target-
ing at nodes. In addition, the FnIII domains of both NF186 and
NrCAM are implicated in Gliomedin binding (Labasque et al.,
2011). Soluble FnIII domains of NF186 has been shown to inhibit
the clustering of Nav channels at hemi-nodes in myelinating co-
cultures (Figure 2). This indicates that thenodal complex assemble
via multiple locking modules.
Other extracellular matrix components and their receptors
may be necessary for the proper formation or stability of the
Schwann cell microvilli, such as laminins and dystroglycan. Spe-
ciﬁc laminin isoforms (α2, α5, γ5) are expressed in the basal
lamina above the nodes of Ranvier (Feltri and Wrabetz, 2005).
In addition, members of the dystrophin-dystroglycan complex
are present at nodes. Mice deﬁcient in laminin-α2 or dystrogly-
can show severe alteration of microvilli and Nav channel clusters
(Saito et al., 2003; Occhi et al., 2005). Similar alterations are also
observed in patients with merosin-deﬁcient congenital muscular
dystrophy type 1A which is associated with a mutation in the gene
encoding laminin-α2 (Occhi et al., 2005). Because Gliomedin and
NrCAM are secreted in the extracellular lumen, it is plausible that
the extracellularmatrixmay stabilize the organization of the nodal
components. The proteoglycans syndecan-3 and -4 and Perlecan
are also enriched in the perinodal processes of Schwann cells early
during development (Goutebroze et al., 2003; Melendez-Vasquez
et al., 2005; Bangratz et al., 2012). However, the function of these
latter components remains to be determined.
NF186, NrCAM, AND BREVICAN/VERSICAN COMPLEX: STRUCTURE AND
FUNCTION AT CNS NODES
At CNS nodes, the molecular mechanisms implicated in the nodal
clustering of Nav channels are different from those involved in the
PNS. In the CNS, myelin sheaths are produced by oligodendro-
cytes, and the nodal gap is contacted by perinodal astrocyte pro-
cesses. In addition, the extracellular matrix in the nodal gap differs
from that in the PNS. The CNS nodes express NF186 and NrCAM,
but lack Gliomedin (Figure 1). The CNS nodal axolemma also
expresses a high molecular weight form of Contactin-1 (Rios et al.,
2000), an Ig CAM implicated in the assembly of the septate-like
junctions at paranodes (see below). In addition, several secreted
proteins are found in the perinodal extracellular matrix surround-
ing the CNS nodes: Tenascin-R, Brevican, Versican, phosphacan,
Bral1, andNeurocan (Weber et al., 1999; Bekku et al., 2009; Dours-
Zimmermann et al., 2009; Susuki et al., 2013; Figure 1). Brevican
and Versican are chondroitin-sulfate proteoglycans that bind
hyaluronic acid to form a negatively charged complex with Bral1,
the brain-speciﬁc hyaluronan-binding link protein. Phosphacan is
a chondroitin-sulfate protoeoglycan which is the secreted form of
the receptor-like protein tyrosine-phosphatase-β, andwhich binds
Tenascin-R andContactin-1with high-afﬁnity (Barnea et al., 1994;
Grumet et al., 1994; Peles et al., 1995; Revest et al., 1999). Finally,
Tenascin-R is a trimeric glycoprotein consisting of EGF-like and
FnIII repeats that may act as a cross-linker between proteogly-
can complexes, and which is also able to bind Neurofascin and
Contactin-1 (Zisch et al., 1992; Volkmer et al., 1998). These nega-
tively charged matrix components may provide a diffusion barrier
around the nodes underlying the accumulation of cations during
saltatory conduction (Bekku et al., 2010), but also the stabilization
of the nodal complex (Susuki et al., 2013).
In contrast to the PNS, the aggregation of the Nav channels at
CNS nodes appears subsequently to the formation of the paran-
odal junctions (Rasband et al., 1999; Jenkins and Bennett, 2002).
Disruption of the paranodal junctions in Caspr-1-deﬁcient mice is
associated with important abnormalities at CNS nodes, including
Nav channels dispersion andpersistent expressionof the immature
Nav1.2 rather than the mature Nav1.6 subunits (Rios et al., 2003).
By contrast, PNS node organization is unaffected in these animals.
The axo-glial contact at nodes also participates in CNS node for-
mation. Neurofascin-deﬁcient mice, which lack NF186 at nodes
and NF155 at paranodes, show disrupted nodal and paranodal
complexes at PNS and CNS. Transgenic expression of NF186 in
neurons or NF155 in glial cells can rescue the accumulation of Nav
channels at CNS nodes inNeurofascin-deﬁcientmice (Zonta et al.,
2008). In contrast to the PNS, the partners of NF186 at CNS node
are yet unknown. NF186 can bind directly to Bral1, Brevican,Ver-
sican, andTenascin-R (Volkmer et al., 1998; Hedstromet al., 2007).
However, during development, these perinodal matrix compo-
nents assemble at nodes after the clustering of NF186 and Nav
channels in the optic nerve. Thus, these matrix components may
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rather be implicated in the maintenance of the nodal structure.
In keeping, Nav channels are properly clustered at CNS nodes
in Tenascin-R-, Versican-, and Bral-1-deﬁcient mice, despite the
loss or dispersion of Tenascin-R and Phosphacan at nodes (Weber
et al., 1999; Dours-Zimmermann et al., 2009; Bekku et al., 2010).
By contrast, the disruption of the paranodal complex and of the
perinodal matrix in Caspr-1/Brevican/Versican triple knock-out
mice induces a signiﬁcant decrease in the number of Nav channel
clusters (Susuki et al., 2013). These results lead to the suggestion
that the formation of the paranodal diffusion barrier is the pri-
mary mechanism enabling the clustering of Nav channels at CNS
nodes, whereas nodal axo-glial contact may be a secondary mech-
anism which allows the maintenance of Nav clusters at nodes or
their formation in absence of paranodes.
CASPR-1, CONTACTIN-1, AND NF155: STRUCTURE AND FUNCTION AT
PARANODES
A peculiar type of cell-cell junctions named the septate-like junc-
tions are encountered at paranodes in both the CNS and PNS
(Einheber et al., 1997). The septate-like junctions seal the termi-
nal loops of myelinated segments to the axolemma on both sides
of the nodal gap. These paranodal junctions are characterized by
intermembrane transverse bands andderive froman ancestral type
of junctions observed in invertebrates, the septate junctions, that
provides paracellular barrier between epithelial cells or between
glial cells insulating axon fascicles (Hortsch and Margolis, 2003;
Faivre-Sarrailh et al., 2004). In vertebrates, the paranodes act as a
fence separating the nodal and juxtaparanodal domains enriched
in Nav and Kv channels, respectively and as an electrical barrier
that promotes AP propagation. The molecular composition of the
paranodal junctions consists of a ternary complex of glycopro-
teins highly conserved during evolution: Caspr-1, Contactin-1,
and NF155. Deﬁciency in either Contactin-1, or Caspr-1, or Neu-
rofascin in mice induces severe neurological defects, disruption of
the septate-like junctions, and a reduction of nerve conduction
velocity (Bhat et al., 2001; Boyle et al., 2001; Sherman et al., 2005;
Zonta et al., 2008; Pillai et al., 2009).
The axonal Caspr-1 and Contactin-1 form cis-heteromers that
are targeted to the paranodal junctions during myelination and
interact in trans with the glial expressed NF155 (Rios et al., 2000;
Charles et al., 2002). NF155 is a 155-kDa splice variant obtained
from the same gene as NF186, but which is expressed only by
the myelinating glial cells (Tait et al., 2000). Caspr-1 belongs to
the neurexin family and is composed of a discoidin domain,
and several laminin-G and EGF-like modules (Menegoz et al.,
1997; Peles et al., 1997; Figure 1). Caspr-1 contains a cyto-
plasmic motif for binding to the scaffolding 4.1B protein and
co-localizes with ankyrin-B, αII- and βII-spectrin at paranodes
(Ogawa et al., 2006). Contactin-1 and NF155 both contain six Ig
domains and four FnIII domains (Figure 1), however, Contactin-1
is a glycosyl-phosphatidyl-inositol anchored protein. The assem-
bly and targeting of the Caspr-1/Contactin-1/NF155 complex at
paranodes is a tightly controlled process. First, Contactin-1 is
required for the transport of the Contactin-1/Caspr-1 complex
to the axonal membrane (Faivre-Sarrailh et al., 2000). This com-
plex is addressed to the cell surface with ER-type mannose-rich
N-glycans that favor its interaction with NF155 (Bonnon et al.,
2007). In addition, selective modules are required for the asso-
ciation of NF155 with the Contactin-1/Caspr-1 complex. The Ig
domains of Contactin-1 mediate its interaction with NF155 and
Caspr-1. Also, the Igdomains 5 and6ofNeurofascin are implicated
in its interaction with Contactin-1. Mutant mice with deletion of
these Ig domains show a disruption of the paranodal septate-like
junctions (Thaxton et al., 2010).
Worth noting, paranodal proteins are lipid raft-associated pro-
teins and this localizationmay favor themaintenance of paranodal
junctions (Ogawa and Rasband, 2009; Labasque and Faivre-
Sarrailh, 2010). Indeed, the deletion of MAL, a raft-associated
proteolipid, results in the disorganizationof the paranodal septate-
like junctions (Schaeren-Wiemers et al., 2004). Also, the mainte-
nance of paranodal junctions appears to be dependent on myelin
galactolipids (Popko, 2000; Ishibashi et al., 2002). Mice lacking raft
gangliosides, notably GM1 and GD1a, show alterations in Caspr-
1/NF155 aggregation at paranodes (Susuki et al., 2007a). In mice
lacking Caspr-1 or gangliosides, the partition of NF155 into lipid
rafts is strongly attenuated.
CONTACTIN-2 AND CASPR-2 AT JUXTAPARANODES
The juxtaparanodal regions are adjacent to the paranodes and are
recovered by compact myelin. The juxtaparanodes are enriched
in Shaker-type Kv1 channels, mainly Kv1.1, Kv1.2, and Kv1.6 sub-
units, but also Kv1.4 in a subtype of sensory ﬁbers (Rasband et al.,
1998; Rasband and Trimmer, 2001). These channels may stabilize
conduction by dampening repetitive ﬁring and maintaining the
internodal resting potential, particularly during development and
in small diameter axons (Rasband et al., 1998; Devaux et al., 2002;
Devaux and Gow, 2008). A heteromeric complex of Contactin-2
(also known as TAG-1) and Caspr-2 is implicated in the forma-
tion of juxtaparanodes in both CNS and PNS (Poliak et al., 2003;
Traka et al., 2003). These molecules are homologs of Contactin-1
and Caspr-1, respectively. Contactin-2 is expressed at the axonal
and glial membranes at juxtaparanodes and displays homophilic
binding activity which mediates adhesive contact. Contactin-2
exists as a glycosyl-phosphatidyl-inositol anchored form, as well
as a released form (Furley et al., 1990). Within the axonal mem-
brane, Contactin-2 forms a cis-complex with Caspr-2 via its Ig
domains which allows the formation of a ternary complex with
the glial-secreted Contactin-2 (Savvaki et al., 2010). Disruption of
Caspr-2 or Contactin-2 in knock-out mice prevents the accumula-
tion of Kv1 channels at juxtaparanodes and induces their diffusion
along the internodes. Albeit, the mis-localization of Kv1 chan-
nels does not affect nerve conduction (Poliak et al., 2003; Traka
et al., 2003), it was reported that Contactin-2-deﬁcient animals
show behavioral deﬁcits and defects in sensori-motor gating and
motor coordination (Savvaki et al., 2008). Strikingly, the trans-
genic expression of Contactin-2 exclusively in oligodendrocytes is
sufﬁcient to rescue juxtaparanode formation and the behavioral
deﬁcits in Contactin-2-deﬁcient mice (Savvaki et al., 2010). These
data highlight the importance of glial-secreted Contactin-2.
Anumberof scaffoldingproteins (4.1B,ankyrin-B,αII- andβII-
spectrin) are expressed at juxtaparanodes with Caspr-2, but also at
paranodes (Denisenko-Nehrbass et al., 2003; Ogawa et al., 2006).
In 4.1B-null mice, the accumulation of Caspr-2, Contactin-2, and
Kv1.1/Kv1.2 at juxtaparanodes is abolished, indicating that 4.1B
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protein is crucial for the formation of juxtaparanodal domains
(Horresh et al., 2010; Buttermore et al., 2011; Cifuentes-Diaz
et al., 2011a; Einheber et al., 2013). In addition, the membrane-
associated guanylate kinases PSD-93 and PSD-95 are concentrated
at juxtaparanodes (Ogawa et al., 2010). However, these proteins
are not required for Kv1 and Caspr-2 clustering at juxtaparanodes
(Horresh et al., 2010; Ogawa et al., 2010).
The juxtaparanodal complex also comprises disintegrin and
metalloproteinase 22 (ADAM22). The deletion of ADAM22 results
in the loss of PSD-93 and -95 at juxtaparanodes, but does not affect
the localization of Kv1 channels and Caspr-2. The exact function
of disintegrin and ADAM22 at juxtaparanodes, thus, remains to
be determined.
Of interest, the loss of the paranodal septate-like junctions in
Caspr-1 and Contactin-1 deﬁcient mice induces the re-location
of the juxtaparanodal proteins near the nodes (Bhat et al., 2001;
Boyle et al., 2001). The role of 4.1B in paranode formation or
maintenance is uncertain. Nonetheless, the transgenic expression
of Caspr-1 lacking the 4.1-binding module in Caspr-null mice
restores paranode formation, but does not restore the accumu-
lation of Kv1 channels at juxtaparanodes (Horresh et al., 2010).
Altogether, these studies indicate that the organization and main-
tenance of juxtaparanodes depend on the combination of three
distinct processes: assembly of an axo-glial complex at juxtapara-
nodes, the linkage of this complex to the cytoskeleton, and the
sequestration of this complex by the paranodal diffusion barrier.
IMPLICATIONS OF CAMs IN INHERITED AND ACQUIRED
NEUROLOGICAL DISORDERS
NODE ALTERATIONS IN INHERITED DEMYELINATING DISORDERS
Although nodal/paranodal CAMs are not the priming factors in
human inherited demyelinating pathologies, it has came to light
during the last decade that demyelination not solely affects the bio-
physical properties of the myelinated axons but also results in the
redistribution or disorganization of the nodal and paranodal com-
ponents. These latter changes likely participate to the conduction
deﬁcits and give important clues about the mechanisms dictating
node formation or re-formation during remyelination. Here, we
will focus on two human pathologies: the demyelinating forms of
Charcot-Marie-Tooth (CMT) disease and Pelizaeus–Merzbacher
disease.
Charcot–Marie-Tooth type 1 are inherited demyelinating dis-
eases affecting peripheral nerves which are caused in most patients
by mutations in Pmp22 (CMT1A), MPZ (CMT1B), and GJB1
genes (CMT1X; see for review Suter and Scherer, 2003). Trembler-J
mice are an animal model of CMT1A and show a point muta-
tion in Pmp22 that is also found in a family with CMT1A (Suter
et al., 1992; Valentijn et al., 1992). In these animals, peripheral
axons show important segmental demyelination, a reduction in
the internodal length, but also a shortening of the paranodal
regions (Devaux and Scherer, 2005). These latter alterations are
associated with abnormally distributed Kv1.1 and Kv1.2 channels
which often ﬂank the nodes or diffuse in demyelinated seg-
ments. In demyelinated segments, Nav channels do not diffuse
along the axons, but remain clustered at hemi-nodes bordering
the Schwann cells (Devaux and Scherer, 2005) and co-localize
with Gliomedin (our unpublished observations). These results
indicate that despite the paranodal alterations and demyelination,
the preservation of the axo-glial contact at nodes is sufﬁcient to
enable the clustering of Nav channels in these animals. Inter-
estingly, hemi-nodes and nodes contain two unusual subunits,
Nav1.8 and Kv3.1b (Devaux and Scherer, 2005), which are nor-
mally absent from PNS nodes. Similar alterations were also found
in P0-deﬁcient mice, an animal model of CMT1B. In these ani-
mals, most axons exhibit disrupted paranodes and abnormally
distributed Kv1.1/Kv1.2 channels (Ulzheimer et al., 2004). In addi-
tion, Nav1.8 subunits were found co-expressed with Nav1.6 at
nodes andhemi-nodes bordering the Schwann cells in P0-deﬁcient
mice. Immunohistological studies of skin biopsies from CMT1A
and CMT1B patients have further conﬁrmed that such alterations
also take place in human patients. Indeed, segmental demyelina-
tion, reduction in the internodal length, and paranodal alterations
have been documented in these patients (Li et al., 2005; Bai
et al., 2006; Saporta et al., 2009). In particular, reorganization of
Kv1.1/Kv1.2 channels was observed in CMT1A patients (Li et al.,
2005), whereas, aberrant expression of Nav1.8 subunits at nodes
was found in CMT1B (Saporta et al., 2009). Altogether, these ﬁnd-
ings indicate that demyelination and/or remyelination affects the
distribution and composition of ion channels in peripheral axons.
Animal models of Pelizaeus–Merzbacher disease have further
revealed some of the mechanisms responsible for the maintenance
of Nav channel clusters in the CNS. Pelizaeus–Merzbacher disease
is a leukodystrophy associated with mutations in the PLP gene.
Myelin-deﬁcient (md) rats and jimpy mice are animal models of
Pelizaeus–Merzbacher disease, and show severe phenotypes caused
by mutations in the PLP gene. In both strains, severe dysmyelina-
tion occurs during the ﬁrst post-natal weeks due to spontaneous
oligodendrocyte cell death (Knapp, 1986; Grinspan et al., 1998).
At P21, few myelinated axons are found in the spinal cord of these
animals, and are ensheathed by only a few myelin wraps. Never-
theless, Nav channels and ankyrin-G remain clustered at node-like
structures, even in regions devoid of oligodendrocytes (Mathis
et al., 2001; Arroyo et al., 2002). By contrast, paranodal regions
are severely impacted in the spinal cord of these animals. Caspr-
1/Contactin-1/NF155 clusters are not detected, and no septate-like
junctions are observed by electron microscopy. Hence, the local-
ization of the Kv1.1/Kv1.2 subunits is strongly altered in md rats
and jimpy mice, and Kv1.1/Kv1.2 subunits abutted the node-like
clusters of Nav, Kv7.2/Kv7.3, and Kv3.1b channels (Mathis et al.,
2001; Arroyo et al., 2002; Devaux et al., 2003, 2004). These results
show that node-like clusters of Nav channels can maintain, at
least temporarily, in the absence of myelin sheaths and paranodal
junctions in jimpy and md animals. The mechanisms responsible
for the maintenance of these node-like structures are, however,
unclear. It is plausible that the presence of astrocyte processes
contacting the node or the preservation of the extracellular matrix
components (Brevican, Phosphacan, andVersican) maintain these
node-like clusters.
ANTIBODIES AGAINST CASPR-2 AND CONTACTIN-2 IN
PERIPHERAL NERVE HYPEREXCITABILITY AND
AUTOIMMUNE ENCEPHALITIS
Numerous studies have implicated the molecular complex found
at juxtaparanodes, named the VGKC complex, as an autoimmune
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target in generalized neuromyotonia (Isaac’s syndrome), per-
sistent facial myokymia, Morvan’s syndrome, and in limbic
encephalitis. Neuromyotonia and myokymia are peripheral nerve
hyperexcitabilities characterized by repetitive muscle contrac-
tions (Gutmann and Gutmann, 2004). Neuromyotonia and
myokymia are often linked to impaired function of the Kv1
channels. Neuromyotonia is also observed in Morvan’s syn-
drome in which it is associated to confusion, autonomic distur-
bance, and delirium or insomnia (Newsom-Davis et al., 2003).
By contrast, limbic encephalitis are characterized by amne-
sia, confusion, seizures, and psychosis (Buckley et al., 2001;
Vincent et al., 2004). Originally, it was suspected that anti-
bodies targeting Kv1.1/Kv1.2/Kv1.6 subunits may be the caus-
ing agents in these disorders (Shillito et al., 1995; Hart et al.,
1997; Buckley et al., 2001; Vincent et al., 2004; Kleopa et al.,
2006). However, recent investigations revealed that most patients
with anti-VGKC-complex antibodies present antibodies against
Leucine-rich glioma inactivated 1 (LGI-1), a secreted protein
associated with presynaptic Kv1 channels (Irani et al., 2010;
Lai et al., 2010). In addition, many patients present antibod-
ies against the juxtaparanodal CAMs: Caspr-2 and Contactin-2
(Irani et al., 2010; Lancaster et al., 2011). These ﬁndings further
emphasized that axonal CAMs are implicated in excitability dis-
orders. Worth noting, sera from patients with neuromyotonia,
Morvan’s syndrome, or limbic encephalitis recognize cell sur-
face antigens and stain the juxtaparanodes in the PNS (Kleopa
et al., 2006; Lancaster et al., 2011). In addition, most of these
patients responded to immunotherapy (Irani et al., 2010; Lai et al.,
2010; Lancaster et al., 2011), suggesting that the autoantibod-
ies are pathogenics and may induce the down-regulation of the
Caspr-2/Contactin-2/Kv1 channel complex. In keeping with this
view, sera from patients with neuromyotonia and anti-VGKC-
complex antibodies signiﬁcantly decreased the density of the
potassium currents in PC-12, NB-1, or CHO-K1 cells express-
ing Kv1.1/Kv1.6 cells when the cells were incubated for 3 days
with the sera (Sonoda et al., 1996; Nagado et al., 1999). However,
these sera did not directly block the potassium currents in these
cells.
The fact that antibodies to Caspr-2 or Contactin-2 are associ-
ated with peripheral nerve hyperexcitabilities originating in motor
axons suggest that these antibodies are susceptible to diffuse across
the paranodal barrier and act on the juxtaparanodal Kv1 channels.
Recent studies indicate that the paranodal regions is not as tightly
sealed as originally thought (Devaux and Gow, 2008; Mierzwa
et al., 2010), thus it is plausible that serum IgG in patients with
Morvan’s syndrome may slowly diffuse toward the juxtaparan-
odes. However, the exact pathogenic mechanisms remain to be
clariﬁed as well as the epitopes recognized by the antibodies. In
some patients, antibodies to Caspr-2 are associated with thymo-
mas (Vincent and Irani, 2010), suggesting a reaction against tumor
antigens.
NODAL ALTERATIONS AND AUTOIMMUNITY AGAINST CAMs IN
MULTIPLE SCLEROSIS
Multiple sclerosis (MS) is an immune-mediated disease character-
ized by CNS demyelination, inﬂammation, axonal degeneration,
and cortical lesions which may lead to numbness, paralysis,
blindness, and other deﬁcits. Alterations of the nodes of Ranvier
have been documented in MS, and Nav channels appear to dif-
fuse along the demyelinated axons in white matter lesions (Moll
et al., 1991; Craner et al., 2004; Coman et al., 2006). In addition,
the paranodal length is increased within demyelinating lesions,
and NF155 immunoreactivity spreads along the internodes, par-
ticularly in damaged or stressed axons (Howell et al., 2006). Worth
noting, paranodal alterations precede the dismantling of the node,
and result in the incursion of the juxtaparanodal Kv1 channels at
nodes and paranodes both in MS and in animal models of MS, the
experimental autoimmune encephalomyelitis (EAE; Howell et al.,
2006; Zoupi et al., 2013). It is very likely that the disruption of the
nodal aggregates of Nav channels participates to the conduction
and locomotor deﬁcits in MS patients. Similarly, the alterations
of the paranodal axo-glial junctions and the redistribution of the
Kv1 channels might contribute to the conduction defects. Sev-
eral mechanisms may be responsible for these alterations. First,
microglia inﬁltration has been found to correlate with nodal and
paranodal alterations in MS patients and in EAE (Howell et al.,
2010). Particularly, the inhibition of microglia activation mini-
mized the nodal/paranodal alterations in animal model of MS.
This indicates that inﬂammation can participate in MS etiology
by affecting node organization.
Secondly, autoimmune attack against the nodal/paranodal
compartments may favor node disruption. Autoantibodies against
Neurofascin (NF186 and NF155) have been detected in a few
patients with MS (Mathey et al., 2007; Elliott et al., 2012). The
immunoabsorption of MS sera over immobilized NF155 abol-
ished the demyelinating and axopathic activities of the serum
in one patient (Elliott et al., 2012). Hence, antibodies to NF155
may participate to the nodal/paranodal alterations. However, the
prevalence of such antibodies appears to be low in MS patients,
as three recent studies indicate that Neurofascin is not the domi-
nant target of antibodies in MS (Devaux et al., 2012; Elliott et al.,
2012; Kawamura et al., 2013). Interestingly, the prevalence of anti-
bodies against NF155 is very high (86%) in patients presenting
combined central and peripheral demyelination (Kawamura et al.,
2013). These patients show a good response to intravenous Ig
injection (IVIg) and plasma exchange, suggesting that these anti-
bodies may participate in the demyelination process. The passive
transfer of anti-NF155 antibodies in rats does not exert pathogenic
effects (Lindner et al., 2013). However, the passive transfer of anti-
NF186 antibodies in rats exacerbates the clinical signs of EAE
and induces axonal loss (Mathey et al., 2007; Lindner et al., 2013).
It is thus likely that antibodies to Neurofascin are pathogenics
and participate to the etiology of MS and other demyelinating
disorders.
In addition to the humoral response, T-cell response against
Contactin-2 has also been reported in MS (Derfuss et al., 2009).
The adoptive transfer of Contactin-2-reactive T-cells induces
EAE in rats characterized by inﬂammation of the gray matter.
Moreover, Contactin-2-reactive T-cells enhance the demyelinat-
ing activity of anti-MOG antibodies by damaging the blood-brain
barrier. Taken together, these ﬁndings suggest that reactive T-cells
may contribute to the pathology of MS. It now appears essential
to determine whether other axonal or glial CAMs are the targets
of autoimmunity in MS.
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AUTOIMMUNITY TO CAMs IN IMMUNE-MEDIATED DEMYELINATING
NEUROPATHIES
A large catalog of neurological disorders affecting peripheral
nerves is suspected to be immune-mediated. Among these,
autoimmune reaction against the nodes of Ranvier is implicated
in Guillain–Barré syndrome (GBS) and chronic inﬂammatory
demyelinating polyradiculoneuropathies (CIDP; Santoro et al.,
1990; Grifﬁn et al., 1996; Hafer-Macko et al., 1996a,b; Cifuentes-
Diaz et al., 2011b). The causes and pathogenesis of GBS and CIDP
remain largely unknown. The presence of inﬂammatory inﬁltrates,
the deposition of IgG and IgM in nerve biopsies, and the response
to IVIg and steroids suggest an autoimmune origin (Dalakas and
Engel, 1980; Schmidt et al., 1996; Bouchard et al., 1999; also see
for review Hughes and Cornblath, 2005; Mehndiratta and Singh,
2007). In particular, the deposition of complement on the abax-
onal surface of the Schwann cells in GBS patients (Hafer-Macko
et al., 1996b; Lu et al., 2000; Wanschitz et al., 2003) has suggested
that the pathology is humorally mediated.
Several recent studies have revealed that autoantibodies in GBS
and CIDP patients target CAMs located at the nodes of Ranvier
and paranodes (Pruss et al., 2011; Devaux et al., 2012; Ng et al.,
2012; Querol et al., 2012; Figure 3). In particular, serum IgG in
nearly 40 % of GBS and 30% of CIDP patients from a Japanese
cohort bind the nodal or paranodal regions of peripheral nerve
ﬁbers (Devaux et al., 2012). Also, the serum IgG in nearly 40 % of
CIDP patients from a French cohort label the nodal or paranodal
regions (our unpublished observations). These results indicate
that the node of Ranvier is the target of the immune attack in
many GBS and CIDP patients. Gliomedin, Neurofascin, Caspr-
1, and Contactin-1 have been identiﬁed as the target antigens in
some GBS and CIDP patients (Pruss et al., 2011; Devaux et al.,
2012; Ng et al., 2012; Querol et al., 2012; Figure 3). The propor-
tion of patients with antibodies against these CAMs is relative low
and ranges from 1 to 8%. Nevertheless, antibodies to Gliomedin
and Contactin-1 are mostly associated with the demyelinating
form of GBS, acute inﬂammatory demyelinating polyneuropa-
thy (AIDP), and with CIDP (Devaux et al., 2012; Querol et al.,
2012). Particularly, Querol et al. (2012) have shown that anti-
bodies to Contactin-1 are associated with a speciﬁc sub-form of
CIDP characterized by an aggressive onset and a poor response to
IVIg. In their study, Ng et al. (2012) have examined the prevalence
of antibodies against Neurofascin and found that the reactivity
against NF155 is more frequent in patients with CIDP. Worth not-
ing, the CIDP patients had IgG4 against NF155. These antibodies
may have an antigen-blocking function, as IgG4 does not bind Fc
receptors and does not activate the complement pathway (Nirula
et al., 2011). Altogether, this suggests that immune attack against
nodal or paranodalCAMscouldbe a commonmechanismmediat-
ing paranodal demyelination in some sub-forms of demyelinating
neuropathies.
FIGURE 3 | Antibodies target nodal CAMs in GBS patients and animal
models. (A) Mouse sciatic nerve ﬁbers were incubated with sera (green)
from AIDP (left panels) or AMAN (right panels) patients which are
reactive against Contactin-1 and Neurofascin, respectively. Fibers were
stained for Caspr (red) to label the paranodes. Pre-incubation of the sera
with soluble Contactin-1-Fc or NF186-Fc abolished the binding of the IgG
at nodes (arrowheads) and paranodes (double arrowheads). (B) Animal
models of GBS were used to evaluate the pathogenic action of
anti-Gliomedin antibodies. In animals immunized against P2 peptide
(EAN-P2), Nav channels (green) are clustered at nodes (arrowheads) and
at hemi-nodes bordering the Schwann cells in demyelinated axons (bar
with arrows). The injection of anti-Gliomedin IgG (here 6 days after IgG
injection) induces the dispersion of Nav channels in demyelinated
segments (between arrows). (C) Node disruption is associated with an
important conduction slowing and loss in ventral roots of EAN-P2 animals
injected with anti-Gliomedin IgG. The amplitude of the nerve potentials
progressively decreased 1, 3, and 6 days post-injection (dpi) of
anti-Gliomedin IgG. Gray arrows indicate the latency of control nerves.
Scale bars: 10 μm. Adapted from Lonigro and Devaux (2009); Devaux
(2012), and Devaux et al. (2012).
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Animal models of GBS have further conﬁrmed that autoan-
tibodies to nodal/paranodal CAMs have pathogenic functions.
Experimental allergic neuritis (EAN) is induced by immunization
of Lewis rats against the P2 peptide (EAN-P2) or puriﬁed myelin
fraction (EAN-PM) that causes a demyelinating pathology remi-
niscent of AIDP (Uyemura et al., 1982; Hahn et al., 1988, 1991).
Of interest, node disruptions are observed in EAN-PM animals
and are associated with antibodies against NF186 and Gliomedin
(Lonigro and Devaux, 2009). In these animals, the disappear-
ance of NF186 and Gliomedin at nodes precedes demyelination,
and results in the loss of Nav channels in demyelinated segments
and in severe conduction defects (Novakovic et al., 1998; Lonigro
and Devaux, 2009). By contrast, EAN-P2 animals do not exhibit
nodal alterations and antibodies to nodal components, despite the
presence of segmental demyelination. This work emphasizes that
antibodies to nodal CAMs may participate to conduction defects
by dismantling axo-glial attachment at nodes and paranodes. Fur-
ther, it was found that immunization against Gliomedin, but not
NF186, induces a chronic neuropathy with conduction block and
nodal dysfunctions (Devaux, 2012). Most importantly, the pas-
sive transfer of anti-Gliomedin IgG in EAN-P2 animals induced
demyelination, nodal disruption, and an important conduction
loss (Figure 3; Devaux, 2012). These results showed that primary
immune reaction against a nodal CAM can be responsible for the
initiation or progression of a demyelinating form of peripheral
neuropathy. The passive transfer of antibodies to Neurofascin has
also been found to exacerbate the pathology of EAN-P2 (Ng et al.,
2012), indicating that these antibodies are pathogenics. In animals
injected with anti-Gliomedin IgG, an important deposition of IgG
was found at nodes preceding demyelination, but no important
deposition of complement (Devaux, 2012). These results sug-
gest that anti-CAMs IgG may induce demyelination by directly
blocking the antigen or through the recruitment of macrophages.
The pathogenic mechanisms responsible for the production of
anti-CAMs antibodies in GBS and CIDP patients are still elusive.
Thus far, no clear correlation has been drawn between infectious
agents and the presence of anti-CAMs antibodies. It is worth not-
ing that an outbreak of polyradiculoneuropathy has been reported
in a swine abattoir and was caused by aerosolized brain tissue
(Meeusen et al., 2012). Nineteen of these patients presented anti-
bodies to theVGKC-complex, and 2 out of 19 recognized Caspr-2.
This emphasizes that the mechanisms leading to the production of
anti-CAM IgG may be very broad as well as the number of target
antigens, and the sub-forms of GBS and CIDP.
NODAL ALTERATIONS IN IMMUNE-MEDIATED AXONAL NEUROPATHIES
Antibodies against NF186 have also been reported in patients with
acute motor axonal neuropathy (AMAN; Devaux et al., 2012).
AMAN is the most predominant form of GBS in China and
Japan, and is characterized by extensive axonal degeneration. Most
patients with AMAN show antibodies against the gangliosides
GM1,GD1a, and GalNAc-GD1a (Yuki et al., 1997; Kuwabara et al.,
1998; Ho et al., 1999). It is currently suspected that these antibod-
ies bind the nodes of Ranvier and ﬁx complement, then induce
node elongation and axonal degeneration (Hafer-Macko et al.,
1996a; Paparounas et al., 1999; O’Hanlon et al., 2003). In keep-
ing, rabbits sensitized against GM1 develop an axonal neuropathy
similar to AMAN (Susuki et al., 2003). In these animals, the depo-
sition of anti-GM1 antibodies and complement at nodes results
in the disruption of the Nav channel clusters and in conduction
block (Susuki et al., 2007b). In addition, anti-GD1a antibodies
can induce node disruption in vivo and in vitro (McGonigal et al.,
2010; Susuki et al., 2012). These ﬁndings indicate that autoim-
mune attack against the nodes of Ranvier can induce conduction
deﬁcits and cause human neuropathies. Thus far, it is unclear
whether anti-NF186 antibodies also participate to the etiology of
AMAN. The passive transfer of anti-NF186 IgG has been found
to exacerbate the axonal loss in EAE (Mathey et al., 2007; Lind-
ner et al., 2013). Because NF186 is located on the axolemma at
PNS nodes, we can suspect that antibodies directed against this
protein might also induce nodal disruption and axonal degen-
eration in peripheral nerves. It is thus plausible that in AMAN
patients, a broad immune reaction against nodal glycolipids and
glycoproteins is responsible for the pathology.
It is worth noting that many axonal neuropathies are asso-
ciated with node dysfunctions, and are now classiﬁed as nodo-
paranodopathies (Uncini et al., 2013). For instance, antibodies to
GD1b are associated with acute sensory ataxic neuropathy (Pan
et al., 2001; Notturno et al., 2008) and result in nodal disruption
and axonal degeneration of sensory axons in rabbits (Susuki et al.,
2012). Also, alterations of the nodes of Ranvier have been docu-
mented in biopsies from patients with chronic idiopathic axonal
polyneuropathies (Cifuentes-Diaz et al., 2011b). It would thus
be interesting to determine the prevalence of antibodies against
nodal/paranodal CAMs in these, but also in other idiopathic
neuropathies.
CONCLUDING REMARKS
Over the last decade, important works have unraveled the nature
of the CAMs underlying the axo-glial contacts at nodes, paran-
odes, and juxtaparanodes. It appears that CAMs participate in the
formation and in the stabilization of the axonal sub-domains in
a very complex way, and require the cooperation of intracellular
anchoring proteins, signaling molecules, and of the extracellular
matrix. In the CNS and PNS, the mechanisms regulating the for-
mation of the nodes are different, albeit the composition of the
nodal membrane is very similar.
As reviewed here, the node of Ranvier is the epicenter of numer-
ous neurological disorders. This is not surprising owing to the
importance of the nodal and paranodal regions in the propaga-
tion of nerve impulse. Subtle changes in the biophysical properties
or excitability of nerve ﬁbers are likely to lead to broadneurological
symptoms such as pain, numbness, confusion, ataxia, or epilepsy.
In addition, immune attack against the nodes of Ranvier might
be responsible for conduction loss and paralysis in demyelinating
disorders and nodo-paranodopathies. Some of the target antigens
have been identiﬁed, but many still remain to be unraveled. Future
works should investigate the pathogenic mechanisms leading to
autoimmunity toward nodal antigens.
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